Prostate Biopsy: Current Status and Limitations

Overview

Journal Rev Urol

Date 2007 Oct 16

PMID 17934565

Citations 21

Authors

Joseph C Presti

Affiliations

Soon will be listed here.

Abstract

The technique of prostate biopsy has evolved over the past 10 years to improve our ability to detect prostate cancer. Extended biopsy schemes can be performed in the office under local anesthesia and are well tolerated. In addition to detection, the role of extended biopsy schemes in refining tumor grading and risk assessment has become better defined. This review discusses the evolution of prostate biopsy techniques from the sextant scheme to the extended scheme and demonstrates the latter's utility in clinical decision making.

Citing Articles

Shape Manipulation of Bevel-Tip Needles for Prostate Biopsy Procedures: A Comparison of Two Resolved-Rate Controllers.

Wang Y, Al-Zogbi L, Liu J, Shepard L, Ghazi A, Tokuda J Annu Int Conf IEEE Eng Med Biol Soc. 2025; 2024:1-7.

PMID: 40038963 PMC: 11884662. DOI: 10.1109/EMBC53108.2024.10781867.

Understanding Spatial Correlation Between Multiparametric MRI Performance and Prostate Cancer.

Zabihollahy F, Naim S, Wibulpolprasert P, Reiter R, Raman S, Sung K J Magn Reson Imaging. 2024; 60(5):2184-2195.

PMID: 38345143 PMC: 11317542. DOI: 10.1002/jmri.29287.

[MR-Guided Targeted Prostate Biopsy from Radiologists' Perspective].

Kim S, Park K J Korean Soc Radiol. 2023; 84(6):1220-1232.

PMID: 38107690 PMC: 10721410. DOI: 10.3348/jksr.2023.0095.

The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment.

Luo H, Wang W, Mai J, Yin R, Cai X, Li Q Front Immunol. 2023; 14:1267918.

PMID: 37881432 PMC: 10597640. DOI: 10.3389/fimmu.2023.1267918.

Fully automated detection and localization of clinically significant prostate cancer on MR images using a cascaded convolutional neural network.

Zhu L, Gao G, Zhu Y, Han C, Liu X, Li D Front Oncol. 2022; 12:958065.

PMID: 36249048 PMC: 9558117. DOI: 10.3389/fonc.2022.958065.

References

Presti Jr J, Chang J, Bhargava V, Shinohara K . The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol. 1999; 163(1):163-6; discussion 166-7. View

Fradet Y, Saad F, Aprikian A, Dessureault J, Elhilali M, Trudel C . uPM3, a new molecular urine test for the detection of prostate cancer. Urology. 2004; 64(2):311-5. DOI: 10.1016/j.urology.2004.03.052. View

Freedland S, Kane C, Amling C, Aronson W, Terris M, Presti Jr J . Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology. 2007; 69(3):495-9. PMC: 3080253. DOI: 10.1016/j.urology.2006.10.036. View

Hodge K, McNeal J, Terris M, Stamey T . Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989; 142(1):71-4; discussion 74-5. DOI: 10.1016/s0022-5347(17)38664-0. View

Freedland S, Aronson W, Terris M, Kane C, Amling C, Dorey F . Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. J Urol. 2003; 169(6):2136-41. DOI: 10.1097/01.ju.0000065588.82511.06. View

Igel T, KNIGHT M, Young P, Wehle M, Petrou S, Broderick G . Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk. J Urol. 2001; 165(5):1575-9. View

Stewart C, Leibovich B, Weaver A, Lieber M . Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001; 166(1):86-91; discussion 91-2. View

Presti Jr J, ODowd G, Miller M, Mattu R, Veltri R . Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol. 2002; 169(1):125-9. DOI: 10.1016/S0022-5347(05)64051-7. View

Stamey T . Making the most out of six systematic sextant biopsies. Urology. 1995; 45(1):2-12. DOI: 10.1016/s0090-4295(95)96168-2. View

10.

Meng M, Franks J, Presti Jr J, Shinohara K . The utility of apical anterior horn biopsies in prostate cancer detection. Urol Oncol. 2003; 21(5):361-5. DOI: 10.1016/s1078-1439(03)00031-0. View

11.

Freedland S, Presti Jr J, Terris M, Kane C, Aronson W, Dorey F . Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. J Urol. 2003; 169(6):2129-35. DOI: 10.1097/01.ju.0000065763.21602.14. View

12.

Karakiewicz P, Bazinet M, Aprikian A, Trudel C, Aronson S, Nachabe M . Outcome of sextant biopsy according to gland volume. Urology. 1997; 49(1):55-9. DOI: 10.1016/S0090-4295(96)00360-3. View

13.

Levine M, Ittman M, Melamed J, Lepor H . Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998; 159(2):471-5; discussion 475-6. DOI: 10.1016/s0022-5347(01)63951-x. View

14.

Raaijmakers R, Wildhagen M, Ito K, Paez A, de Vries S, Roobol M . Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam. Urology. 2004; 63(2):316-20. DOI: 10.1016/j.urology.2003.09.028. View

15.

Hong Y, Lai F, Chon C, McNeal J, Presti Jr J . Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies. Urol Oncol. 2004; 22(1):7-10. DOI: 10.1016/S1078-1439(03)00147-9. View

16.

King C, McNeal J, Gill H, Presti Jr J . Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys. 2004; 59(2):386-91. DOI: 10.1016/j.ijrobp.2003.10.014. View

17.

Gore J, Shariat S, Miles B, Kadmon D, Jiang N, Wheeler T . Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 2001; 165(5):1554-9. View

18.

Stephen Jones J, Patel A, Schoenfield L, Rabets J, Zippe C, Magi-Galluzzi C . Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol. 2006; 175(2):485-8. DOI: 10.1016/S0022-5347(05)00211-9. View

19.

Babaian R, Toi A, Kamoi K, Troncoso P, Sweet J, Evans R . A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol. 1999; 163(1):152-7. View

20.

McNeal J, Redwine E, Freiha F, Stamey T . Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988; 12(12):897-906. DOI: 10.1097/00000478-198812000-00001. View